Keap Calm, and Carry on Covalently
The DOI matches its Crossref record; 137 of the 140 references it cites were found in a registry or an index.
Abstract
The Nrf2-Keap1 system plays a major role in cellular defense against oxidative stress. Upon exposure to electrophiles, the cysteine-rich protein Keap1 is covalently modified, and it is this modification of Keap1 that allows the accumulation and subsequent nuclear translocation of Nrf2 where it induces the transcription of over 100 protective genes. This mechanism can be exploited in drug discovery approaches to diseases such as chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), asthma, and neurodegenerative diseases like multiple sclerosis (MS) and Parkinson's, utilizing the modification of Keap1 by electrophiles, compounds that would not normally be considered useful in drug discovery programs. This Perspective discusses the development of potential therapies based on potent electrophiles, such as isothiocyanates and Michael acceptors, that, far from being associated with toxic events, can actually initiate a range of beneficial protective pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, some covalent inhibitors with reactive functional groups tend to be unattractive for drug discovery because of the poor pharmacokinetic values, especially high clearance [137].”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [137]
Citations
Cites
2 retracted
Malhotra, D., Thimmulappa, R., Navas-Acien, A., Sandford, A., Elliott, M., Singh, A., Chen, L., Zhuang, X., Hogg, J., Pare, P., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200803-380oc · Cited by 357
RetractedMukherjee, S., Gangopadhyay, H., & Das, D. K. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0728146 · Cited by 124
RetractedItoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630
BIOLOGY AND BIOCHEMISTRY OF GLUCOSINOLATES
Halkier, B. A., & Gershenzon, J. (2006) · Annual Review of Plant Biology · doi:10.1146/annurev.arplant.57.032905.105228 · Cited by 2,271
Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
Zhang, Y., Talalay, P., Cho, C. G., & Posner, G. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2399 · Cited by 1,682
Zhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
Taguchi, K., Motohashi, H., & Yamamoto, M. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01473.x · Cited by 1,478
Research works printed but not linked: 2
- Johansson M. H., 2012, Mini-Rev. Med. Chem., 12, 1330
- MacNee W., 2005, Curr. Drug Targets, 4, 627
Cited by
The Keap1–Nrf2–ARE Pathway As a Potential Preventive and Therapeutic Target: An Update
Lu, M., Ji, J., Jiang, Z., & You, Q. (2016) · Medicinal Research Reviews · doi:10.1002/med.21396 · Cited by 790
“ARE pathway and their usefulness as potential preventive and therapeutic agents in this journal.12 In a 2013 publication, Wilson et al.13 discussed the development of potential therapies that were based on potent electrophiles, such as isothiocyanates and Michael acceptors, which react covalently…”
BackgroundGehringer, M., & Laufer, S. A. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01153 · Cited by 714
Tetrazoles via Multicomponent Reactions
Neochoritis, C. G., Zhao, T., & Dömling, A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00564 · Cited by 599
Activators and inhibitors of NRF2: a review of their potential for clinical development
Robledinos-Antón, N., Fernández-Ginés, R., Manda, G., & Cuadrado, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9372182 · Cited by 413
Targeted Covalent Inhibitors for Drug Design
Baillie, T. A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601091 · Cited by 578
Bauer, R. A. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.05.005 · Cited by 534
Nrf2/Keap1/ARE signaling: Towards specific regulation
Ulasov, A. V., Rosenkranz, A. A., Georgiev, G. P., & Sobolev, A. S. (2022) · Life Sciences · doi:10.1016/j.lfs.2021.120111 · Cited by 508
Davies, T. G., Wixted, W. E., Coyle, J. E., Griffiths-Jones, C., Hearn, K., McMenamin, R., Norton, D., Rich, S. J., Richardson, C., Saxty, G., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00228 · Cited by 322
Self-citationLu, M., Liu, T., Jiao, Q., Ji, J., Tao, M., Liu, Y., You, Q., & Jiang, Z. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.01.063 · Cited by 310
Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO
Cleasby, A., Yon, J., Day, P. J., Richardson, C., Tickle, I. J., Williams, P. A., Callahan, J. F., Carr, R., Concha, N., Kerns, J. K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098896 · Cited by 258
“A number of small molecule antagonists of Keap1 are known, the majority of which are electrophiles believed to function by covalent modification of the Keap1 cysteine residues responsible for sensing oxidative stress [35–39].”
BackgroundSelf-citationJiang, Z.-Y., Lu, M.-C., Xu, L., Yang, T.-T., Xi, M.-Y., Xu, X.-L., Guo, X.-K., Zhang, X.-J., You, Q.-D., & Sun, H.-P. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5000529 · Cited by 252
Oxidative Stress in Alzheimer’s Disease: Are We Connecting the Dots?: Miniperspective
Rosini, M., Simoni, E., Milelli, A., Minarini, A., & Melchiorre, C. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm400970m · Cited by 201
Binding Mode and Structure–Activity Relationships around Direct Inhibitors of the Nrf2–Keap1 Complex
Jnoff, E., Albrecht, C., Barker, J. J., Barker, O., Beaumont, E., Bromidge, S., Brookfield, F., Brooks, M., Bubert, C., Ceska, T., et al. (2014) · ChemMedChem · doi:10.1002/cmdc.201300525 · Cited by 176
Nrf2 as regulator of innate immunity: A molecular Swiss army knife!
Battino, M., Giampieri, F., Pistollato, F., Sureda, A., de Oliveira, M. R., Pittalà, V., Fallarino, F., Nabavi, S. F., Atanasov, A. G., & Nabavi, S. M. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.12.012 · Cited by 169
Yao, J., Zhang, B., Ge, C., Peng, S., & Fang, J. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf505075n · Cited by 164
Peng, S., Zhang, B., Meng, X., Yao, J., & Fang, J. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00410 · Cited by 141
Xie, L., Chen, Y., Qin, L., Wen, Y., Xie, J., Tan, J.-X., Huang, Y. P., Cao, Z. Y., & He, W. (2019) · Organic Chemistry Frontiers · doi:10.1039/c9qo01240k · Cited by 134
Methylglyoxal Metabolism and Aging-Related Disease: Moving from Correlation toward Causation
Kold-Christensen, R., & Johannsen, M. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.10.003 · Cited by 146
Jiang, Z.-Y., Lu, M.-C., & You, Q.-D. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00586 · Cited by 121
Zhao, W., Xie, P., Bian, Z., Zhou, A., Ge, H., Zhang, M., Ding, Y., & Zheng, L. (2015) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.5b01602 · Cited by 120
Development of a covalent inhibitor of gut bacterial bile salt hydrolases
Adhikari, A. A., Seegar, T. C. M., Ficarro, S. B., McCurry, M. D., Ramachandran, D., Yao, L., Chaudhari, S. N., Ndousse-Fetter, S., Banks, A. S., Marto, J. A., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0467-3 · Cited by 113
Dual protection of hydroxytyrosol, an olive oil polyphenol, against oxidative damage in PC12 cells
Peng, S., Zhang, B., Yao, J., Duan, D., & Fang, J. (2015) · Food & Function · doi:10.1039/c5fo00097a · Cited by 120
Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators
Jain, A. D., Potteti, H., Richardson, B. G., Kingsley, L., Luciano, J. P., Ryuzoji, A. F., Lee, H., Krunic, A., Mesecar, A. D., Reddy, S. P., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.08.049 · Cited by 104
Peng, S., Yao, J., Liu, Y., Duan, D., Zhang, X., & Fang, J. (2015) · Food & Function · doi:10.1039/c5fo00214a · Cited by 106
Design and development of Nrf2 modulators for cancer chemoprevention and therapy: a review
Sova, M., & Saso, L. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s172612 · Cited by 104
“22,28,58 Magesh et al provided a detailed description (with representative examples) of ten chemically distinct classes of indirect small-molecule Keap1-Nrf2 interaction inhibitors, namely Michael acceptors (caffeic acid phenethyl ester (1) (Figure 3), curcumin (2), chal-cones), oxidizable…”
BackgroundHeightman, T. D., Callahan, J. F., Chiarparin, E., Coyle, J. E., Griffiths-Jones, C., Lakdawala, A. S., McMenamin, R., Mortenson, P. N., Norton, D., Peakman, T. M., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00279 · Cited by 94
Self-citationThe design and development of covalent protein-protein interaction inhibitors for cancer treatment
Cheng, S.-S., Yang, G.-J., Wang, W., Leung, C.-H., & Ma, D.-L. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00850-0 · Cited by 98
“Additionally, some covalent inhibitors with reactive functional groups tend to be unattractive for drug discovery because of the poor pharmacokinetic values, especially high clearance [137].”
BackgroundMetal-free Oxidative Coupling of Aromatic Alkenes with Thiols Leading to ( E )-Vinyl Sulfones
Wang, L., Yue, H., Yang, D., Cui, H., Zhu, M., Wang, J., Wei, W., & Wang, H. (2017) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.7b00994 · Cited by 94
Jiang, Z.-Y., Xu, L., Lu, M.-C., Chen, Z.-Y., Yuan, Z.-W., Xu, X.-L., Guo, X.-K., Zhang, X.-J., Sun, H.-P., & You, Q.-D. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00185 · Cited by 88
Cui, H., Liu, X., Wei, W., Yang, D., He, C., Zhang, T., & Wang, H. (2016) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.5b02579 · Cited by 93
Peng, S., Hou, Y., Yao, J., & Fang, J. (2017) · Food & Function · doi:10.1039/c7fo00054e · Cited by 96
Modeling covalent-modifier drugs.
Awoonor-Williams, E., Walsh, A. G., & Rowley, C. N. (2017) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2017.05.009 · Cited by 90
Li, J., Li, C., Yang, S., An, Y., Wu, W., & Jiang, H. (2016) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.6b00162 · Cited by 87
Electrophilic Warhead-Based Design of Compounds Preventing NLRP3 Inflammasome-Dependent Pyroptosis
Cocco, M., Garella, D., Di Stilo, A., Borretto, E., Stevanato, L., Giorgis, M., Marini, E., Fantozzi, R., Miglio, G., & Bertinaria, M. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501072b · Cited by 85
Zhuang, C., Wu, Z., Xing, C., & Miao, Z. (2017) · MedChemComm · doi:10.1039/c6md00500d · Cited by 84
Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors
Mou, Y., Wen, S., Li, Y., Gao, X., Zhang, X., & Jiang, Z. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112532 · Cited by 87
Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway
Richardson, B. G., Jain, A. D., Speltz, T. E., & Moore, T. W. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.04.019 · Cited by 75
The neuroprotective activities of natural products through the Nrf2 upregulation
Tavakkoli, A., Iranshahi, M., Hasheminezhad, S. H., Hayes, A. W., & Karimi, G. (2019) · Phytotherapy Research · doi:10.1002/ptr.6427 · Cited by 72
In Situ Observation of Thiol Michael Addition to a Reversible Covalent Drug in a Crystalline Sponge
Duplan, V., Hoshino, M., Li, W., Honda, T., & Fujita, M. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201509801 · Cited by 70
Yao, J., Ge, C., Duan, D., Zhang, B., Cui, X., Peng, S., Liu, Y., & Fang, J. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf405553v · Cited by 63
Martino, R. M. C. D., Pruccoli, L., Bisi, A., Gobbi, S., Rampa, A., Martínez, A., Pérez, C., Martínez‐González, L., Paglione, M., Schiavi, E. D., et al. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00363 · Cited by 61
Zhang, M., Liu, J., Yu, Y., Liu, X., Shang, X., Du, Z., Xu, M., & Zhang, T. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c00523 · Cited by 68
Wang, L., Cai, X., Shi, M., Xue, L., Kuang, S., Xu, R., Qi, W., Li, Y., Ma, X., Zhang, R., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112385 · Cited by 58
Wong, M. H. L., Bryan, H. K., Copple, I. M., Jenkins, R. E., Chiu, P. H., Bibby, J., Berry, N. G., Kitteringham, N. R., Goldring, C. E., O’Neill, P. M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01292 · Cited by 56
Зенков, Н. К., Kozhin, P. M., Владимирович, Ч. А., Мартинович, Г. Г., Кандалинцева, Н. В., & Брониславовна, М. Е. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917050030 · Cited by 64
How Reactive are Druggable Cysteines in Protein Kinases?
Awoonor‐Williams, E., & Rowley, C. N. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00454 · Cited by 58
Sun, Y., Xu, L., Zheng, D., Wang, J., Liu, G., Mo, Z., Liu, C., Zhang, W., Yu, J., Xing, C., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102793 · Cited by 54
NRF2-targeted therapeutics: New targets and modes of NRF2 regulation
de la Vega, M. R., Dodson, M. B., Chapman, E., & Zhang, D. D. (2016) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2016.10.005 · Cited by 57
Binding thermodynamics and kinetics guided optimization of potent Keap1–Nrf2 peptide inhibitors
Lu, M.-C., Chen, Z.-Y., Wang, Y.-L., Jiang, Y.-L., Yuan, Z.-W., You, Q.-D., & Jiang, Z.-Y. (2015) · RSC Advances · doi:10.1039/c5ra16262a · Cited by 55
New Approaches to Treating Alzheimer's Disease
Zheng, H., Fridkin, M., & Youdim, M. B. H. (2015) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s13210 · Cited by 59
Michaelides, I. N., & Collie, G. W. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01882 · Cited by 54
Xu, L., Zhu, J., Xu, X., Zhu, J., Li, L., Xi, M., Jiang, Z., Zhang, M.-Y., Liu, F., Lu, M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00170 · Cited by 51
Activators of Nrf2 to Counteract Neurodegenerative Diseases
Amoroso, R., Maccallini, C., & Bellezza, I. (2023) · Antioxidants · doi:10.3390/antiox12030778 · Cited by 53
“As previously described, Keap1 ensures that Nrf2 concentration is kept very low thanks to oxidative stress sensors; however, if the oxidative stress increases, the ubiquitination and subsequent degradation of Nrf2 are blocked as a result of the reaction of electrophilic species with the cysteine residue in Keap1 prote…”
BackgroundGeneration of ArS- and ArSe-Substituted 4-Quinolone Derivatives Using Sodium Iodide As an Inducer
Ghosh, P., Nandi, A. K., Chhetri, G., & Das, S. (2018) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.8b01426 · Cited by 47
Qu, L., Ji, L., Wang, C., Luo, H., Li, S., Peng, W., Yin, F., Lu, D., Liu, X., Kong, L., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113441 · Cited by 47
Identification of 4-aminoquinoline core for the design of new cholinesterase inhibitors
Chen, Y., Bian, Y., Sun, Y., Chen, K., Yu, S., Fu, T., Li, W., Pei, Y., & Sun, H. (2016) · PeerJ · doi:10.7717/peerj.2140 · Cited by 52
“, 1986), oxidative stress (Wilson et al., 2013), neuroinflammation (Linker et al.”
BackgroundMolecular recognition between potential natural inhibitors of the Keap1-Nrf2 complex
Bello, M., & Morales‐González, J. A. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.07.117 · Cited by 46
Michael Acceptors as Anti-Cancer Compounds: Coincidence or Causality?
Andrés, C. M. C., de la Lastra, J. M. P., Munguira, E. B., Andrés, C., & Pérez‐Lebeña, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116099 · Cited by 52
Gong, X., Chen, J., Liu, J., & Wu, J. (2017) · Organic Chemistry Frontiers · doi:10.1039/c7qo00634a · Cited by 45
Jiang, Z., Lu, M., & You, Q. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01121 · Cited by 46
Ding, Y., Li, D., Ding, C., Wang, P., Liu, Z., Wold, E. A., Ye, N., Chen, H., White, M. A., Shen, Q., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01514 · Cited by 45
Characterization of the Antioxidant Effects of γ‐Oryzanol: Involvement of the Nrf2 Pathway
Rungratanawanich, W., Abate, G., Serafini, M. M., Guarienti, M., Catanzaro, M., Marziano, M., Memo, M., Lanni, C., & Uberti, D. L. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/2987249 · Cited by 46
“Among the antioxidant pathways, the Nrf2 pathway promotes the transcription of NQO1, HO-1, and GSS because of the presence of an antioxidant responsive element (ARE) sequence in their promoter region [11, 12].”
BackgroundBeyond canonical PROTAC: biological targeted protein degradation (bioTPD)
Wang, H., Zhou, R., Xu, F., Yang, K., Zheng, L., Zhao, P., Shi, G., Dai, L., Xu, C., Yu, L., et al. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00385-8 · Cited by 51
“The Nrf2Keap1 pathway plays a major role in cellular defense against oxidative stress [116].”
BackgroundTau degradation in Alzheimer's disease: Mechanisms and therapeutic opportunities
Wang, L., Banesh, S., Kumar, R., Schedin‐Weiss, S., Tjernberg, L. O., & Winblad, B. G. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70048 · Cited by 63
Aldini, G., Carini, M., Yeum, K., & Vistoli, G. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.01.017 · Cited by 44
Briehl, M. M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.04.002 · Cited by 43
Zielgerichtete kovalente Inhibitoren für das Wirkstoffdesign
Baillie, T. A. (2016) · Angewandte Chemie · doi:10.1002/ange.201601091 · Cited by 44
Diethelm‐Varela, B., Ai, Y., Liang, D., & Xue, F. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190401100519 · Cited by 43
Norton, D., Bonnette, W. G., Callahan, J. F., Carr, M. G., Griffiths-Jones, C., Heightman, T. D., Kerns, J. K., Nie, H., Rich, S. J., Richardson, C. J., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01351 · Cited by 43
Self-citationTargeting the Nrf2/Amyloid-Beta Liaison in Alzheimer’s Disease: A Rational Approach
Simoni, E., Serafini, M. M., Caporaso, R., Marchetti, C., Racchi, M., Minarini, A., Bartolini, M., Lanni, C., & Rosini, M. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00100 · Cited by 41
Lu, M., Shao, H.-L., Liu, T., You, Q., & Jiang, Z. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112734 · Cited by 42
Liu, G., Hou, R., Xu, L., Zhang, X., Yan, J., Xing, C., Xu, K., & Zhuang, C. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00170 · Cited by 38
Peng, S., Hou, Y., Yao, J., & Fang, J. (2019) · BioFactors · doi:10.1002/biof.1488 · Cited by 37
CovBinderInPDB: A Structure-Based Covalent Binder Database
Guo, X.-K., & Zhang, Y. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01216 · Cited by 37
Elhalem, E., Recio, R., Werner, S., Lieder, F., Calderón‐Montaño, J. M., López‐Lázaro, M., Fernández, I., & Khiar, N. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.052 · Cited by 40
Meng, N., Tang, H., Zhang, H., Jiang, C., Su, L., Min, X., Zhang, W., Zhang, H., Miao, Z., Zhang, W., et al. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.02.010 · Cited by 38
Reactive Oxygen Species: Participation in Cellular Processes and Progression of Pathology
Шлапакова, Т. И., Kostin, R. K., & Tyagunova, E. E. (2020) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162020050222 · Cited by 39
Paul, S., Shrestha, R., Edison, T. N. J. I., Lee, Y. R., & Kim, S. H. (2016) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201600429 · Cited by 35
Zhang, L., Xu, L., Chen, H., Zhang, W., Xing, C., Qu, Z., Yu, J., & Zhuang, C. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113599 · Cited by 35
Polar Recognition Group Study of Keap1-Nrf2 Protein–Protein Interaction Inhibitors
Lu, M., Tan, S.-J., Ji, J., Chen, Z., Yuan, Z., You, Q., & Jiang, Z. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00407 · Cited by 35
Choi, J., Kim, S., Yoo, J. S., Kim, H. J., Kim, H. J., Kim, B. E., Lee, E. H., Lee, Y. S., Park, J., & Park, K. D. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113103 · Cited by 36
The Use of Antioxidants as Potential Co-Adjuvants to Treat Chronic Chagas Disease
Maldonado, E., Rojas, D., Urbina, F., & Solari, A. (2021) · Antioxidants · doi:10.3390/antiox10071022 · Cited by 38
Lu, M., Yuan, Z., Jiang, Y.-L., Chen, Z., You, Q., & Jiang, Z. (2016) · Molecular BioSystems · doi:10.1039/c6mb00030d · Cited by 35
Emerging crosstalk between long non-coding RNAs and Nrf2 signaling
Bhattacharjee, S., Li, J., & Dashwood, R. H. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.07.011 · Cited by 31
Zhao, W., & Zhou, A. (2015) · ChemCatChem · doi:10.1002/cctc.201500673 · Cited by 31
Synthesis, evaluation, and metabolism of novel [6]-shogaol derivatives as potent Nrf2 activators
Zhu, Y., Wang, P., Zhao, Y., Yang, C., Clark, A., Leung, T., Chen, X. L., & Sang, S. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.03.026 · Cited by 30
Covalent allosteric modulation: An emerging strategy for GPCRs drug discovery
Bian, Y., Jun, J. J., Cuyler, J., & Xie, X. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112690 · Cited by 33
Ji, L., Qu, L., Wang, C., Peng, W., Li, S., Yang, H., Luo, H., Yin, F., Lu, D., Liu, X., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112965 · Cited by 33
Hydrochloric Acid-Promoted Intermolecular 1,2-Thiofunctionalization of Aromatic Alkenes
Li, X., Guo, Y., & Shen, Z. (2018) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.7b03263 · Cited by 30
Unleashing the Power of Covalent Drugs for Protein Degradation
Fu, M., Jin, H., Wang, S., Shen, L., Liu, H., Liu, Y., Zheng, Y., & Dai, X. (2025) · Medicinal Research Reviews · doi:10.1002/med.22101 · Cited by 34
“The Keap1 ‐ Nrf2 signaling pathway has been implicated in therapeutic strategies for various chronic neurodegenerative conditions, including chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), and asthma [235, 237, 238].”
Targeted Covalent Inhibition of Telomerase
Betori, R. C., Liu, Y., Wu, D., Mishra, R., Cohen, S., Kron, S. J., & Scheidt, K. A. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.9b00945 · Cited by 30
Generation of ArS-substituted flavone derivatives using aryl thiols as sulfenylating agents
Zhao, W., Xie, P., Bian, Z., Zhou, A., Ge, H., Niu, B., & Ding, Y. (2015) · RSC Advances · doi:10.1039/c5ra10763f · Cited by 28
Xu, L., Liu, T., Wang, L., Li, L., Wu, Y., Li, C., Di, B., You, Q., & Jiang, Z. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3271617 · Cited by 28
“In addition, Nrf2 can be modulated by multiple protein kinases, making it a promising regulatory node in cellular defense systems [17].”
BackgroundLv, L., & Li, Z. (2018) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.8b01621 · Cited by 28
Price, K. E., Armstrong, C. M., Imlay, L. S., Hodge, D. M., Pidathala, C., Roberts, N. J., Park, J., Mikati, M. O., Sharma, R., Lawrenson, A. S., et al. (2016) · Scientific Reports · doi:10.1038/srep36777 · Cited by 36
Identification of Non-Electrophilic Nrf2 Activators from Approved Drugs
Zhang, Q., Chu, X., Jiang, L.-H., Liu, M., Mei, Z., & Zhang, H. (2017) · Molecules · doi:10.3390/molecules22060883 · Cited by 30
“To date, the activation of Nrf2 can take place through either a direct antioxidant or indirect antioxidant mechanism, and most of the research has focused on electrophilic indirect Nrf2 activators [3,23,24].”
BackgroundGhosh, P., Chhetri, G., Nandi, A. K., Sarkar, S., Saha, T., & Das, S. (2019) · New Journal of Chemistry · doi:10.1039/c9nj01922g · Cited by 28
Advances in KEAP1-based PROTACs as emerging therapeutic modalities: Structural basis and progress
Chen, J., Feng, D., Zhu, R., Li, H., & Chen, L. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103781 · Cited by 31
“Kelch-like ECH-associated protein 1 (KEAP1) functions as a substrate adaptor protein for the Cullin 3 (CUL3)/Ring-Box1 (RBX1)-dependent E3 ligase complex [1 – 3].”
Medicinal Chemistry of Inhibiting RING-Type E3 Ubiquitin Ligases
Blaquière, N., Villemure, E., & Staben, S. T. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01451 · Cited by 26
No quiet surrender: molecular guardians in multiple sclerosis brain
Steinman, L. (2015) · Journal of Clinical Investigation · doi:10.1172/jci74255 · Cited by 26
“Binding of heme to BACH1 releases the complex from DNA, allowing NRF2-mediated transcription (77–80).”
Background
Metadata
- Authors
- Wilson, A. J., Kerns, J. K., Callahan, J. F., & Moody, C. J.
- Affiliations
- University of Nottingham (GB)
- GlaxoSmithKline (United States) (US)
- Corresponding author
- Moody, Christopher J.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2013-07-25
- Volume
- 56
- Issue
- 19
- Pages
- 7463-7476
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2081058334
- Cited by
- 171
- References
- 140
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 7 · 2023: 10 · 2022: 11 · 2021: 9 · 2020: 17 · 2019: 14 · 2018: 18 · 2017: 14 · 2016: 25 · 2015: 19 · 2014: 11 · 2013: 1
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Keywords
- Nrf2/Keap1 pathway, electrophiles, oxidative stress, isothiocyanates, Michael acceptors, Nrf2 nuclear translocation, chronic kidney disease, chronic obstructive pulmonary disease, asthma, multiple sclerosis, Parkinson's disease, neurodegenerative diseases
- MeSH terms
- Kelch-Like ECH-Associated Protein 1, Animals, Cell Nucleus, Esters, Humans, Ketones, Protein Binding, Protein Conformation, Sulfoxides, Isothiocyanates, Active Transport, Cell Nucleus, Intracellular Signaling Peptides and Proteins, NF-E2-Related Factor 2, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.